UnitedHealth Group (NYSE:UNH) Price Target Increased to $560.00 by Analysts at Barclays

UnitedHealth Group (NYSE:UNH) had its target price lifted by Barclays from $534.00 to $560.00 in a research note released on Wednesday morning, Benzinga reports. The firm currently has an overweight rating on the healthcare conglomerate’s stock.

A number of other analysts also recently weighed in on UNH. Piper Sandler dropped their target price on UnitedHealth Group from $584.00 to $581.00 and set an overweight rating for the company in a research report on Wednesday, January 17th. Oppenheimer restated an outperform rating and issued a $610.00 target price on shares of UnitedHealth Group in a research report on Wednesday, January 17th. Stephens restated an overweight rating and issued a $605.00 target price on shares of UnitedHealth Group in a research report on Thursday, February 8th. Erste Group Bank reaffirmed a hold rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. Finally, Truist Financial reaffirmed a buy rating and issued a $600.00 price target on shares of UnitedHealth Group in a research note on Wednesday. Four research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of Moderate Buy and an average target price of $570.05.

UnitedHealth Group Price Performance

UNH stock opened at $501.29 on Wednesday. UnitedHealth Group has a one year low of $436.38 and a one year high of $554.70. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79. The stock has a market cap of $462.16 billion, a PE ratio of 30.64, a P/E/G ratio of 1.31 and a beta of 0.54. The firm has a 50 day simple moving average of $488.63 and a two-hundred day simple moving average of $515.13.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. The business had revenue of $99.80 billion for the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company’s revenue for the quarter was up 8.6% on a year-over-year basis. During the same quarter last year, the business posted $6.26 earnings per share. On average, analysts predict that UnitedHealth Group will post 27.74 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were paid a dividend of $1.88 per share. The ex-dividend date was Friday, March 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.50%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 45.97%.

Insider Activity

In related news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. In related news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

Institutional Investors Weigh In On UnitedHealth Group

Several hedge funds have recently added to or reduced their stakes in the stock. Kraft Davis & Associates LLC lifted its holdings in shares of UnitedHealth Group by 3.4% during the third quarter. Kraft Davis & Associates LLC now owns 577 shares of the healthcare conglomerate’s stock valued at $294,000 after purchasing an additional 19 shares in the last quarter. Iron Horse Wealth Management LLC lifted its holdings in shares of UnitedHealth Group by 1.6% during the third quarter. Iron Horse Wealth Management LLC now owns 1,217 shares of the healthcare conglomerate’s stock valued at $614,000 after purchasing an additional 19 shares in the last quarter. Secure Asset Management LLC lifted its holdings in shares of UnitedHealth Group by 0.8% during the third quarter. Secure Asset Management LLC now owns 2,456 shares of the healthcare conglomerate’s stock valued at $1,238,000 after purchasing an additional 19 shares in the last quarter. Bensler LLC lifted its holdings in shares of UnitedHealth Group by 0.3% during the third quarter. Bensler LLC now owns 7,293 shares of the healthcare conglomerate’s stock valued at $3,677,000 after purchasing an additional 19 shares in the last quarter. Finally, Texas Capital Bancshares Inc TX lifted its holdings in shares of UnitedHealth Group by 1.1% during the third quarter. Texas Capital Bancshares Inc TX now owns 1,695 shares of the healthcare conglomerate’s stock valued at $855,000 after purchasing an additional 19 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.